Jeil Pharma Holdings Inc
Symbol: 002620.KS
KSC
10530
KRWMarktpreis heute
-20.3172
P/E-Verhältnis
0.0956
PEG-Verhältnis
161.65B
MRK Kapital
- 0.00%
DIV Rendite
Jeil Pharma Holdings Inc (002620-KS) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 234375.12 | 59131 | 53402.7 | 47223.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 86457.8 | 22092.4 | 18643.2 | 18642.9 | |||||||||||||||||
balance-sheet.row.net-receivables | 782964.19 | 198695.1 | 181304.5 | 167949 | |||||||||||||||||
balance-sheet.row.inventory | 531549.74 | 125280.1 | 113265.7 | 114242.9 | |||||||||||||||||
balance-sheet.row.other-current-assets | 11507.57 | 1421 | 4943.5 | 5728.2 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1560396.62 | 384527.2 | 352916.4 | 335143.7 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 921883.08 | 228862.4 | 233120.1 | 212965.1 | |||||||||||||||||
balance-sheet.row.goodwill | 265259.92 | 44862.3 | 73465.9 | 151801.2 | |||||||||||||||||
balance-sheet.row.intangible-assets | 48297.94 | 13093.2 | 9472.3 | 3781.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 313557.86 | 57955.5 | 82938.2 | 155582.5 | |||||||||||||||||
balance-sheet.row.long-term-investments | 389896.62 | 199929.7 | 67118.8 | 60379.6 | |||||||||||||||||
balance-sheet.row.tax-assets | -64449.59 | 5448.7 | 188.5 | 1451.9 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 470872.57 | 3273.5 | 129395.1 | 126898.6 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 2031760.54 | 495469.8 | 512760.6 | 557277.7 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 3592157.16 | 879997 | 865677 | 892421.4 | |||||||||||||||||
balance-sheet.row.account-payables | 636258.45 | 154050 | 162967.4 | 159388.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 600673.06 | 161332.5 | 119087.3 | 94964.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 3382.6 | 774.7 | 1159.8 | 684.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 49892.41 | 10500 | 17477 | 20107.5 | |||||||||||||||||
Deferred Revenue Non Current | 9246.16 | 1198 | 0 | 36229.2 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 145216.43 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 205023.86 | 95305.2 | 74662 | 17971.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 262882.12 | 65175.1 | 87379.8 | 94084.1 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 6892.95 | 1198 | 1869.2 | 2383.2 | |||||||||||||||||
balance-sheet.row.total-liab | 1882055.08 | 477810.9 | 445884.6 | 392107.7 | |||||||||||||||||
balance-sheet.row.preferred-stock | 43492.24 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 31946.71 | 7986.7 | 7986.7 | 7986.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 309763.33 | -14357.5 | 98244.6 | 172151.3 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 477369.96 | 152732.4 | 226471 | 226109.7 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 498974.16 | 173099.5 | 5062.4 | 5482.9 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1361546.4 | 319461.2 | 337764.7 | 411730.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3592157.16 | 879997 | 865677 | 892421.4 | |||||||||||||||||
balance-sheet.row.minority-interest | 348555.67 | 82724.9 | 82027.8 | 88583.2 | |||||||||||||||||
balance-sheet.row.total-equity | 1710102.08 | 402186.1 | 419792.5 | 500313.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3592157.16 | - | - | - | |||||||||||||||||
Total Investments | 476354.42 | 222022.1 | 85761.9 | 79022.5 | |||||||||||||||||
balance-sheet.row.total-debt | 651763.51 | 173030.5 | 136564.4 | 115072 | |||||||||||||||||
balance-sheet.row.net-debt | 503846.19 | 135991.9 | 101804.9 | 86491.2 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -11642.57 | -16249.7 | -83145 | -12870 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 12556.11 | 12556.1 | 10905.1 | 8983.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | -8558.55 | -60632 | 0 | -664 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 578.03 | 578 | 472.5 | 163.2 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -28544.09 | -28544.1 | -22115.2 | 14405.2 | |||||||||||||||||
cash-flows.row.account-receivables | -12922.7 | -12922.7 | -14120.2 | 8024.7 | |||||||||||||||||
cash-flows.row.inventory | -12170.48 | -12170.5 | 1347.3 | 9341.5 | |||||||||||||||||
cash-flows.row.account-payables | -9848.6 | -9848.6 | 3357.5 | 10023.5 | |||||||||||||||||
cash-flows.row.other-working-capital | 6397.69 | 6397.7 | -12699.8 | -12984.4 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 31195.44 | 87876.1 | 73080.5 | 3385.4 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -4415.63 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -9909.58 | -9836.6 | -21410 | -23736.1 | |||||||||||||||||
cash-flows.row.acquisitions-net | 87.64 | 87.6 | 24 | -1500 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -3775.84 | -3769.8 | -0.3 | -10005.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 169.7 | 999.5 | |||||||||||||||||
cash-flows.row.other-investing-activites | 172.76 | 93.8 | 3652.9 | 41567.1 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -13425.02 | -13425 | -17563.7 | 7325.1 | |||||||||||||||||
cash-flows.row.debt-repayment | -31854.19 | -22634.4 | -5156.3 | -6125 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7497.6 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -397 | -31210.2 | |||||||||||||||||
cash-flows.row.dividends-paid | -362 | -1133.9 | -1474.9 | -1590 | |||||||||||||||||
cash-flows.row.other-financing-activites | 54328.13 | 44384.3 | 51942.1 | 19190 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 20616.07 | 20616.1 | 44914 | -12237.6 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -496.29 | -496.3 | -369.4 | -93.2 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 2279.12 | 2279.1 | 6178.7 | 8397.4 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 147917.32 | 37038.6 | 34759.5 | 28580.8 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 145638.2 | 34759.5 | 28580.8 | 20183.4 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -4415.63 | -4415.6 | -20802.2 | 13403.1 | |||||||||||||||||
cash-flows.row.capital-expenditure | -9909.58 | -9836.6 | -21410 | -23736.1 | |||||||||||||||||
cash-flows.row.free-cash-flow | -14325.21 | -14252.3 | -42212.2 | -10333.1 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 801550.85 | 794713.6 | 792964.7 | 762568.1 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 590068.68 | 592891.6 | 612481.6 | 582061.3 | |||||||||||||||||
income-statement-row.row.gross-profit | 211482.17 | 201822 | 180483.1 | 180506.8 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 45642.2 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 43332.62 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 37213.16 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 20406.32 | 4200.9 | 67032.4 | 63480.2 | |||||||||||||||||
income-statement-row.row.operating-expenses | 193054.13 | 190231.2 | 188031.1 | 189481.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 783122.82 | 783122.8 | 800512.7 | 771542.9 | |||||||||||||||||
income-statement-row.row.interest-income | 1731.42 | 1731.4 | 499.5 | 247.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 10672.11 | 10672.1 | 5952.3 | 3288.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 37213.16 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -34901.84 | -34901.8 | -76312.7 | -7682.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 20406.32 | 4200.9 | 67032.4 | 63480.2 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -34901.84 | -34901.8 | -76312.7 | -7682.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 10672.11 | 10672.1 | 5952.3 | 3288.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 15380.48 | 12556.1 | -63218.7 | 8983.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 34548.17 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 18428.04 | 11590.8 | -7548 | 1552.9 | |||||||||||||||||
income-statement-row.row.income-before-tax | -16473.8 | -23311 | -83860.6 | -6129.2 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -740.82 | -740.8 | -715.6 | 6740.8 | |||||||||||||||||
income-statement-row.row.net-income | -7978.87 | -16249.7 | -83145 | -12870 |
Häufig gestellte Frage
Wie hoch ist die Jeil Pharma Holdings Inc (002620.KS) Gesamtvermögen?
Jeil Pharma Holdings Inc (002620.KS) Gesamtvermögen ist 879996990707.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 395204780875.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.264.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -933.170.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.010.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.023.
Was ist der Jeil Pharma Holdings Inc (002620.KS) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -16249744239.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 173030541501.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 190231187725.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 37038628042.000.